Pages that link to "Q44844098"
Jump to navigation
Jump to search
The following pages link to Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer (Q44844098):
Displaying 50 items.
- Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer (Q33921635) (← links)
- Association of metabolic syndromes and risk factors with ampullary tumors development: a case-control study in China. (Q33948411) (← links)
- The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy. (Q35390159) (← links)
- The metabolic syndrome: A high-risk state for cancer? (Q35607405) (← links)
- The association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomy (Q36080375) (← links)
- Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy (Q36284738) (← links)
- Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume. (Q36284900) (← links)
- Relationships between Prostate-Specific Antigen, Prostate Volume, and Components of Metabolic Syndrome in Healthy Korean Men. (Q36413307) (← links)
- Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer: A Meta-Analysis of Observational Studies (Q36891781) (← links)
- Testosterone, diabetes mellitus, and the metabolic syndrome (Q37016343) (← links)
- Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats (Q37040298) (← links)
- Racial differences in risk of prostate cancer associated with metabolic syndrome (Q37248315) (← links)
- Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice (Q37251457) (← links)
- Insulin Receptor Isoform Variations in Prostate Cancer Cells (Q37291918) (← links)
- Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. (Q37385840) (← links)
- Insulin resistance and hyperinsulinaemia in the development and progression of cancer (Q37434345) (← links)
- Benign prostatic hyperplasia: does lifestyle play a role? (Q37667643) (← links)
- Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? (Q37887276) (← links)
- Urological aspects of the metabolic syndrome (Q37910709) (← links)
- Metabolic syndrome components and risk factors for pancreatic adenocarcinoma: a case-control study in China (Q38055281) (← links)
- High-density lipoprotein and prostate cancer: an overview (Q38132333) (← links)
- Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer (Q38832862) (← links)
- Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia (Q38913900) (← links)
- Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study (Q39125305) (← links)
- Diet-induced hyperinsulinemia accelerates growth of androgen-independent PC-3 cells in vitro (Q39428124) (← links)
- Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. (Q39852959) (← links)
- The association between metabolic syndrome and prostate-specific antigen levels (Q39858236) (← links)
- Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy? (Q40262619) (← links)
- Low HDL levels and the risk of death, sepsis and malignancy (Q40432809) (← links)
- Cardiovascular Disease Risk Factors: How Relevant in African Men With Prostate Cancer Receiving Androgen-Deprivation Therapy? (Q40988056) (← links)
- The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study (Q41767239) (← links)
- Febuxostat improves outcome in a rat model of cancer cachexia (Q41769219) (← links)
- Is central obesity, hyperinsulinemia and dyslipidemia associated with high-grade prostate cancer? A descriptive cross-sectional study (Q42590351) (← links)
- Metabolic syndrome and urologic diseases (Q42757693) (← links)
- Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database (Q43478062) (← links)
- Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts (Q46879124) (← links)
- A stage-dependent link between metabolic syndrome components and incident prostate cancer (Q50055076) (← links)
- The relationship between prostate cancer and presence of metabolic syndrome and late-onset hypogonadism (Q50626099) (← links)
- Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study. (Q52651276) (← links)
- Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia. (Q52889641) (← links)
- Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats. (Q54207094) (← links)
- Estrogens and prostate cancer (Q57107678) (← links)
- Blood lipid levels and prostate cancer risk; a cohort study (Q57307183) (← links)
- Features of the metabolic syndrome and prostate cancer in African-American men (Q57714758) (← links)
- Bone metastases are infrequent in patients with newly diagnosed prostate cancer: Analysis of their clinical and pathologic features (Q57780614) (← links)
- Diabetes and prostate cancer risk in the REDUCE trial (Q63966154) (← links)
- Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship (Q64122520) (← links)
- Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia (Q81499466) (← links)
- Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer (Q88264960) (← links)
- Pre- and post-radical prostatectomy testosterone levels in prostate cancer patients (Q91118004) (← links)